Score Overview
Explore the 2021 public Archive ranking →
Where Tekla Healthcare Investors has ranked, year by year
Showing 5 years ranking history by HDB Score.
Has not reached the top 50 on HDB Score in any year we have ranked.
- HQH
2003: 66.9% · 2021: 43.0% · free through 2021 · longest runs
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-09-29 | $ 20.95 | — |
1 Year2025-09-29 | $ 15.93 | 31.48% |
5 Years2021-09-29 | $ 14.73 | 42.24% |
10 Years2016-09-29 | $ 8.86 | 136.55% |
20 Years2006-09-29 | $ 2.82 | 7x |
30 Years1996-09-27 | $ 1.05 | 19x |
All Time1988-01-05 | $ 0.26 | 79x |
| Period | Last Price2026-09-29 | 1 Year2025-09-29 | 5 Years2021-09-29 | 10 Years2016-09-29 | 20 Years2006-09-29 | 30 Years1996-09-27 | All Time1988-01-05 |
|---|---|---|---|---|---|---|---|
| Price | $ 20.95 | $ 15.93 | $ 14.73 | $ 8.86 | $ 2.82 | $ 1.05 | $ 0.26 |
| Return | — | 31.48% | 42.24% | 136.55% | 7x | 19x | 79x |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
Reported in USD
| Year | |||
|---|---|---|---|
| 2025 | $ 99M | $ 98M | $ 59.00 |
| 2024 | $ 10M | $ 184M | $ 56.00 |
| 2023 | $ 58M | $ 56M | $ 214.00 |
| 2022 | -$ 192M | -$ 194M | $ 792.00 |
| 2021 | $ 157M | $ 155M | $ 935.00 |
| 2020 | $ 242M | $ 241M | $ 2M |
| 2019 | -$ 143M | -$ 145M | $ 1M |
| 2018 | $ 70M | $ 69M | $ 927.00 |
| 2017 | $ 123M | $ 121M | $ 6M |
| 2016 | $ 4M | -$ 56M | $ 883.00 |
| 2015 | $ 4M | $ 96M | $ 209.55K |
| 2014 | $ 2M | $ 222M | $ 1.12K |
| 2013 | $ 1M | $ 200M | |
| 2012 | $ 5M | $ 157M | |
| 2011 | $ 1M | $ 32M | |
| 2010 | $ 3M | $ 19M | |
| 2009 | $ 720K | -$ 36M | |
| 2008 | $ 2M | -$ 23M | |
| 2007 | $ 2M | $ 75M | |
| 2006 | $ 3M | -$ 15M | |
| 2005 | $ 1M | $ 62M | $ 300K |
| 2004 | $ 690K | $ 13M | $ 200K |
| 2003 | $ 990K | $ 54M | $ 2M |
| 2002 | $ 1M | -$ 75M | |
| 2001 | $ 2M | -$ 140M | $ 600K |
| 2000 | $ 2M | $ 286M | $ 300K |
| 1998 | $ 640K | -$ 47M | $ 200K |
| 1997 | $ 680K | $ 33M | |
| 1996 | $ 250K | $ 29M | $ 300K |
Tekla Healthcare Investors fundamental performance
Between 2005 and 2025, revenue grew from $ 1M to $ 99M and net income grew from $ 62M to $ 98M. Revenue increased in 11 of those 20 years; net income in 10.
Across Tekla Healthcare Investors's full reported history, from 1996 to 2025, revenue grew from $ 250K to $ 99M and net income grew from $ 29M to $ 98M. Revenue increased in 54% of the years measured; net income in 54%.
Tekla Healthcare Investors currently holds a 20-year HDB Score of 4.1 out of 10. How the HDB Score is calculated.
Membership
Continue HQH’s history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 3,814 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
